• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Aethlon Medical Inc.

Aethlon Medical completes $3.8m offering

January 23, 2020 By Sean Whooley

Aethlon Medical (NSDQ:AEMD) announced that it completed its previously announced registered direct offering of nearly 1.9 million shares of its common stock for nearly $3.8 million in proceeds. The shares, offered at a purchase price of $2 per share, totaled approximately $3.77 million in gross proceeds. Aethlon additionally issued unregistered warrants to purchase up to 942,689 […]

Filed Under: Business/Financial News, Funding Roundup, Oncology Tagged With: Aethlon Medical Inc.

Aethlon prices $5m offering

December 13, 2019 By Sean Whooley

Aethlon Medical (NSDQ:AEMD) shares plummetted -44.8% at $1.10 per share today after it announced that it priced an underwritten public offering of common stock worth approximately $5 million. San Diego-based Aethlon intends to use approximately $700,000 of the $5 million in gross proceeds for its planned clinical trials for the Hemopurifier over the next 12 months. […]

Filed Under: Business/Financial News, Funding Roundup, Wall Street Beat Tagged With: Aethlon Medical Inc.

Aethlon Medical wins FDA nod for Hemopurifier cancer trial

May 7, 2019 By Brad Perriello

Aethlon Medical (NSDQ:AEMD) said today that it won an investigational device exemption from the FDA for an early feasibility study of its Hemopurifier device in patients with head and neck cancer in combination with the standard pembrolizumab (Keytruda) care. San Diego-based Aethlon said the small trial will enroll 10 to 12 patients with advanced head and […]

Filed Under: Blog Tagged With: Aethlon Medical Inc., FDA

HydroCision names Tranchemontagne as CEO | Personnel Moves – March 12, 2019

March 12, 2019 By Fink Densford

HydroCision said early this month that it tapped former Smith & Nephew (NYSE:SNN) exec Alain Tranchemontagne as its new chief executive officer. Prior to joining Boston-based HydroCision, Tranchemontagne held a position as U.S. business commercial development senior VP at Smith & Nephew. Before joining Smith & Nephew, Tranchemontagne also held positions at Covidien in senior marketing roles […]

Filed Under: Business/Financial News Tagged With: Aethlon Medical Inc., camberspine, Humacyte, HydroCision Inc., Invictus Medical, IRRAS, Johnson and Johnson, MediWounds, qureai, Senseonics, Smith & Nephew, SynCardia, V-Wave, Virta Health

Gerresheimer taps Metzner as CFO | Personnel Moves – December 14, 2018

December 14, 2018 By Fink Densford

Gerresheimer said late last month that it tapped Dr. Bernd Metzner as its new chief financial officer, set to take position at the latest by July 1 next year. Prior to joining the Dusseldorf-based company, Metzner acted as CFO at Ströer, a position he took up in June 2014. He also held positions at Bayer […]

Filed Under: Business/Financial News Tagged With: Aethlon Medical Inc., Amazon, Bayer, Berkshire Hathaway, berkshiresterilemanufacturing, Common Sensing, Frazier Healthcare Ventures, gerresheimer, GI Dynamics, JP Morgan Chase, oculartherapeutix, Organovo, Personnel Moves

Aethlon Medical biz Exosome Science readies CTE biomarker trial of ex-NFL players

March 22, 2018 By Fink Densford

Aethlon Medical (NSDQ:AEMD) subsidiary Exosome Sciences said today it is launching a study of a biomarker candidate intended to detect and monitor chronic traumatic encephalopathy in a sample of retired NFL players. Screening is expected to begin in the coming weeks, Exosome Sciences said, and looks to enroll former NFL players at high risk of suffering from […]

Filed Under: Clinical Trials, Neurological Tagged With: Aethlon Medical Inc., Exosome Sciences

Aethlon Medical wins FDA EAP designation for Hemopurifier

September 12, 2017 By Fink Densford

Aethlon Medical (NSDQ:AEMD) said today it received an Expedited Access Pathway designation for its Aethlon Hemopurifier designed for treating life-threatening viruses. The San Diego-based company said its Hemopurifier has been validated to capture a “broad spectrum of viruses that are highly glycosylated”, which includes lethal strains of pandemic influenza, mosquito-borne viruses and hemorrhagic viruses with no currently […]

Filed Under: Blood Management, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Aethlon Medical Inc.

Aethlon looks fast-track FDA nod for Hemopurifier blood filter through EAP

June 22, 2017 By Fink Densford

Aethlon Medical (NSDQ:AEMD) said today it is submitting an expedited access pathway application to the FDA seeking a breakthrough technology designation for its hemopurifier. Aethlon’s Hemopurifier device is a single-use, disposable cartridge designed to target and filter out viruses or tumor-secreted exosomes. Blood flows through the cartridge into nearly 3,000 hollow fibers with pores 250 nanometers in diameter. […]

Filed Under: Blood Management, Regulatory/Compliance Tagged With: Aethlon Medical Inc.

Aethlon touts Hemopurifier feasibility study results

March 13, 2017 By Sarah Faulkner

Aethlon Medical (NSDQ:AEMD) said today that it finished an FDA-approved feasibility study for its Hemopurifier device in health-compromised patients. Previously, the device was used under the FDA’s emergency-use authorization in patients infected with Hepatitis C, HIV and the Ebola virus. Aethlon’s Hemopurifier device is a single-use, disposable cartridge designed to target and filter out viruses or tumor-secreted […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA) Tagged With: Aethlon Medical Inc.

Tracking the neurodegenerative disease haunting American football

January 25, 2017 By Sarah Faulkner

Aethlon Medical (NSDQ:AEMD) subsidiary Exosome Sciences said today that it plans to support a clinical trial involving retired NFL players to study a biomarker-based diagnostic to detect and monitor chronic traumatic encephalopathy in living people. CTE, a neurodegenerative disease found in American football players and people with a history of repetitive trauma to the head, […]

Filed Under: Clinical Trials, Diagnostics, Neurological Tagged With: Aethlon Medical Inc., Exosome Sciences

Aethlon’s blood filtration device as broad countermeasure for infectious diseases

November 18, 2016 By Sarah Faulkner

In the midst of a devastating global crisis 2 years ago, a Ugandan physician was infected with Ebola in Sierra Leone as he was treating patients. He was hospitalized at the Frankfurt University Hospital and 12 days later he was unconscious, suffering from multiple organ failure. By the time Aethlon Medical (NSDQ:AEMD) got permission to use […]

Filed Under: Blood Management, Food & Drug Administration (FDA), Research & Development Tagged With: Aethlon Medical Inc., MassDevice Q&A

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS